Conformis: Independent Proxy Advisory Firm ISS Recommends Conformis
BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) - Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. ("ISS"), has recommended that Conformis stockholders vote "FOR" the pending merger transaction with restor3d. As previously announced, under the terms [...]
Read full article »
Conformis is a Massachusetts-based medical device company that designs and manufactures products such as implants and surgical instruments to treat knee and hip replacement.
Read more